Systematic review and meta-analysis appraising efficacy and safety of adrenaline for adult cardiopulmonary resuscitation by Ludwin, Kobi et al.
Address for correspondence: Lukasz Szarpak, Assoc. Prof. PhD, MBA, Bialystok Oncology Center, ul. Ogrodowa 12,  
15–027 Białystok, Poland, tel: +48 500186225, e-mail: lukasz.szarpak@gmail.com
Received: 12.08.2020 Accepted: 3.09.2020
This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download 




2021, Vol. 28, No. 2, 279–292
DOI: 10.5603/CJ.a2020.0133 




Systematic review and meta-analysis appraising 
efficacy and safety of adrenaline for adult  
cardiopulmonary resuscitation
Kobi Ludwin1, Kamil Safiejko2, Jacek Smereka1, 3, Klaudiusz Nadolny4, 5,  
Maciej Cyran6, Ruslan Yakubtsevich7, Milosz J. Jaguszewski8, Krzysztof J. Filipiak9,  
Lukasz Szarpak1, 2, 6, Antonio Rodríguez-Núñez10
1Polish Society of Disaster Medicine, Warsaw, Poland 
2Bialystok Oncology Center, Bialystok, Poland 
3Department of Emergency Medical Service, Wroclaw Medical University, Wroclaw, Poland 
4Department of Emergency Medical Service, Higher School of Strategic Planning in Dabrowa Gornicza, Poland 
5Faculty of Medicine, Katowice School of Technology, Katowice, Poland 
6Maria Sklodowska-Curie Medical Academy in Warsaw, Poland 
7Department of Anesthesiology and Intensive Care, Grodno State Medical University, Grodno, Belarus 
8First Department of Cardiology, Medical University of Gdansk, Poland 
9First Chair and Department of Cardiology, Medical University of Warsaw, Poland 
10Pediatric Intensive Care Unit, University Hospital of Santiago de Compostela, Spain
This paper was guest edited by Prof. Togay Evrin
Abstract
Background: There is a beneficial effect of adrenaline during adult cardiopulmonary resuscitation 
(CPR) from cardiac arrest but there is also uncertainty about its safety and effectiveness. The aim of 
this study was to evaluate the use of adrenaline versus non-adrenaline CPR.
Methods: PubMed, ScienceDirect, Embase, CENTRAL (Cochrane Central Register of Controlled Trials)  
and Google Scholar databases were searched from their inception up to 1st July 2020. Two reviewers 
independently assessed eligibility and risk of bias, with conflicts resolved by a third reviewer. Risk ratio 
(RR) or mean difference of groups were calculated using fixed or random-effect models. 
Results: Nineteen trials were identified. The use of adrenaline during CPR was associated with a sig-
nificantly higher percentage of return of spontaneous circulation (ROSC) compared to non-adrenaline 
treatment (20.9% vs. 5.9%; RR = 1.87; 95% confidence interval [CI] 1.37–2.55; p < 0.001). The use 
of adrenaline in CPR was associated with ROSC at 19.4% and for non-adrenaline treatment — 4.3% 
(RR = 3.23; 95% CI 1.89–5.53; p < 0.001). Survival to discharge (or 30-day survival) when using 
adrenaline was 6.8% compared to non-adrenaline treatment (5.5%; RR = 0.99; 95% CI 0.76–1.30;  
p = 0.97). However, the use of adrenaline was associated with a worse neurological outcome (1.6% vs. 
2.2%; RR = 0.57; 95% CI 0.42–0.78; p < 0.001). 
Conclusions: This review suggests that resuscitation with adrenaline is associated with the ROSC 
and survival to hospital discharge, but no higher effectiveness was observed at discharge with favorable 
neurological outcome. The analysis showed higher effectiveness of ROSC and survival to hospital dis-
charge in non-shockable rhythms. But more multicenter randomized controlled trials are needed in the 
future. (Cardiol J 2021; 28, 2: 279–292)
Key words: adrenaline, epinephrine, cardiac arrest, cardiopulmonary resuscitation,  
outcome, return of spontaneous circulation, meta-analysis, systematic review
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Introduction
Sudden cardiac arrest (SCA) is a challenge 
for medical personnel, especially in the context of 
emergency medical teams, where there are a limited 
number of personnel in the resuscitation team 
[1, 2]. Adrenaline has been a key component of 
advanced life support algorithms for many years. 
Adrenaline is a catecholamine, showing sympa-
thomimetic activity dependent on direct or indi-
rect stimulation of a1, a2, b1, b2 receptors. For 
cardiopulmonary resuscitation (CPR), the effect 
on a1 receptors is significant due to vasoconstric-
tion. This increases the aortic diastolic pressure, 
which increases coronary perfusion pressure and 
cerebral perfusion pressure. As numerous studies 
indicate, coronary perfusion pressure is closely 
correlated with the survival of cardiac arrest [3, 4]. 
It is recommended by both the European Resusci-
tation Council (ERC) [5], as well as the American 
Heart Association (AHA) [6]. The use of adrenaline 
during CPR does not have the highest class of rec-
ommendations. Although adrenaline can improve 
global cerebral and coronary blood flow, due to its 
vascular contraction, the microcirculatory flow may 
be reduced [7, 8]. There is a consistent pattern in 
studies that suggests that adrenaline can initially 
resume heart function and increase chances of 
survival, but can generally increase brain injury [9].
The objective herein, was to compare the 
survival to hospital discharge rates in patients with 
cardiac arrest treated with and without adrena-
line. In this meta-analysis, we hypothesized that 
adrenaline confirms benefit over placebo or non-
-adrenaline treatment under adult CPR as seen 
by the rate of return of spontaneous circulation 
(ROSC) and survival to hospital discharge. 
Methods
This systematic review and meta-analysis 
were conducted following the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses 
(PRISMA) statement for conducting and reporting 
results [10] and The Meta-analysis Of Observa-
tional Studies in Epidemiology (MOOSE) guide-
lines [11] for observational studies. The systematic 
review protocol has not been registered. Ethical 
approval was not required for this meta-analysis.
Literature search strategy and  
inclusion criteria
An electronic database search without lan-
guage restrictions was performed in a standardized, 
unblinded manner by two independent reviewers 
(K.L. and M.C.). Inter-reviewer disagreements were 
resolved by consultation of the third author (J.S.). The 
search strategy was first applied to PubMed, Web 
of Science, Embase, ScienceDirect, the Cochrane 
Central Register of Controlled Trials (CENTRAL) 
databases from their inception, to July 1, 2020. In addi-
tion to these sources, manual searches in Google and 
Google Scholar, and web pages of reliable organiza-
tions (gray literature) were conducted. An additional 
manual cross-reference and related-article search was 
conducted to identify articles that were not found 
through prior searches.
Inclusive criteria: (a) Research types: rand-
omized controlled trials, quasi-randomized trials, 
observational studies; (b) Research subjects: hu-
man studies involved adult patients with cardiac 
arrest were included in our meta-analysis. Studies 
which were preprint were also included. Case-
-control studies, non-trials conducted on simulated 
models, editorials, reviews, guidelines, meta-
-analysis and theoretical models were excluded 
from the review.
The following search terms were used: “adrena-
line” OR “epinephrine” AND “cardiac arrest” OR 
“heart arrest” OR “circulation arrest” OR “circulatory 
arrest” OR “induced heart arrest” OR “heart stand 
still” OR “cardiac ventric* fibrillation” OR “heart ven-
tric* fibrillation” OR “pulseless ventric* tachycardia” 
OR “asysto*” OR “pulseless electrical activity”.
Data extraction
Two independent reviewers conducted the 
data extraction and checked by each other (K.L. 
and J.S.). A third reviewer (L.S.) was available to 
resolve cases for which eligibility was unclear. For 
each study, a record of the first author, publication 
time, sample size, country, research type, the 
primary and secondary measures; inclusion and 
exclusion criteria; and study quality was included.
Outcomes
The primary outcome of the current meta-
-analysis was survival to discharge, defined as the 
rate of survival to hospital discharge or survival at 
30 days. The secondary outcome was the ROSC 
and survival to discharge with favorable neurologi-
cal outcome defined as a score of 3 or less on the 
modified Rankin scale [12] or 14 or 15 points in 
Glasgow Coma Scale [13].
Quality assessment of included studies
Quality assessment was performed by two 
reviewers (K.S. and K.J.F.). Inter-reviewer disa-
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greements were resolved by consultation (J.S.). 
For quality assessment of randomized controlled 
trials (RCTs), the Cochrane Collaboration risk 
assessment tool for RCTs was used. Studies were 
graded as “low risk”, “high risk” or “unclear” 
for: random sequence generation, allocation con-
cealment, blinding of participants and personnel, 
blinding of outcome assessment, incomplete out-
come data, selective reporting, and other biases. 
The review authors’ judgments about each risk 
of bias item are provided in the Supplementary 
Digital File 1. The Newcastle-Ottawa qual-
ity assessment scale was used to appraise the 
outcome of interest for the cohort study. The 
modified Newcastle-Ottawa scale was used for 
the cross-sectional study [14] and is shown in 
Supplementary Digital File 1.
Statistical analysis
All statistical analyses were performed with 
Review Manager Software 5.4 (The Cochrane 
Collaboration, Oxford, Copenhagen, Denmark) 
to carry out the single-arm meta-analysis. Out-
comes were summarized using the Mantel-Haen-
szel risk ratios (RRs) or mean differences with 
a 95% confidence interval (CI). When the con-
tinuous outcome was reported in a study as 
median, range, and interquartile range, means 
and standard deviations were estimated us-
ing the formula described by Hozo et al. [15]. 
Heterogeneity was quantitatively evaluated by 
I2 statistic (no heterogeneity, I2 = 0–25%; mod-
erate heterogeneity, I2 = 25–50%; large het-
erogeneity, I2 = 50–75%; extreme heterogeneity, 
I2 = 75–100%). The random-effects model was 
used for I2 > 50%; otherwise, the fixed effects 
model was employed. All statistical tests were 
two-sided and were considered when p < 0.05.
Results
The systematic literature search identified 
1282 relevant publications. After the review of 
titles and abstracts, 45 studies were selected as 
being potentially eligible for inclusion into this 
systematic review. After reading the full-text 
articles, 5 RCTs (published between 1995 and 
2018) including 4951 participants [16–20] and 14 
nonrandomized trials (published between 1994 and 
2016) including 91,537 participants [13, 21–33] 
were finally included (Fig. 1). Other information 
was listed in the Tables 1 and 2 of characteristics 
of included studies.
Return of spontaneous circulation
Twelve studies reported ROSC [13, 16–18, 
20–22, 24–28]. Polled analysis showed that the 
use of adrenaline during CPR was associated with 
a significantly higher percentage of ROSC com-
pared to non-adrenaline treatment (20.9% vs. 
5.9%; RR = 1.87; 95% CI 1.37–2.55; p < 0.001; 
Fig. 2). The above trend was reflected in both RCTs 
(35.9% vs. 12.8%; RR = 2.28; 95% CI 1.49–3.49; 
p < 0.001) and observational studies (19.9% vs. 
5.8%; RR = 1.70; 95% CI 1.15–2.53; p = 0.009). 
The incidence of ROSC for shockable rhythms 
for adrenaline use was 24.0% and 28.1% for non-
-adrenaline use (RR = 0.86; 95% CI 0.77–0.96; 
p = 0.007). For non-shockable rhythms, the re-
verse trend was observed (Fig. 3). The use of 
adrenaline in the CPR process was associated with 
ROSC at 19.4% and for non-adrenaline treatment 
— 4.3% (RR = 3.23; 95% CI 1.89–5.53; p < 0.001).
Survival to discharge 
Survival to discharge (or 30 day survival) 
using adrenaline was 6.8% compared to the non-
-adrenaline treatment (5.5%; RR = 0.99; 95% CI 
0.76–1.30; p = 0.97; Fig. 4) [16–18, 20–24, 26–33]. 
In the case of non-shockable rhythms, the use 
of adrenaline compared to non-adrenaline treat-
ment was associated with higher survival to hos-
pital discharge rate (3.9% vs. 2.9%, respectively; 
RR = 1.16; 95% CI 0.86–1.55; p = 0.32; Fig. 5) 
[17, 21, 22, 24, 28–30, 33]. For shockable rhythms, 
higher survival to discharge was observed in the 
non-adrenaline group compared to the adrenaline 
group (27.1% vs. 15.7%, respectively; RR = 0.63; 
95% CI 0.56–0.70; p < 0.001) [17, 21, 22, 28, 29, 33].
Survival to discharge with favorable  
neurological outcome
Ten studies [13, 16, 17, 20–22, 24, 26–28] report-
ed survival to discharge with a favorable neurological 
outcome and indicated that the use of adrenaline 
was associated with worse outcome (1.6% vs. 2.2%; 
RR = 0.57; 95% CI 0.42–0.78; p < 0.001). 
In randomized clinical trials [16, 17, 20], the 
use of adrenaline was associated with a slightly 
higher percentage of patients with survival and 
favorable neurological outcome compared to the 
non-adrenaline group (2.9% vs. 2.4%; RR = 1.21; 
95% CI 0.95–1.54; p = 0.13). The opposite trend 
was observed for observational studies (Suppl. 
Digital File 1) [13, 21, 22, 24, 26–28].
The analysis in subgroups concerning the 
type of rhythm showed that in cases of shockable 
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rhythms, the use of adrenaline was associated with 
statistically significant worse prognosis (survival to 
discharge with the favorable neurological outcome) 
than the non-adrenaline group (7.4% vs. 19.1%, 
respectively; RR = 0.40; 95% CI 0.35–0.45; p < 
< 0.001; Suppl. Digital File 1) [21, 22, 24, 28, 33]. 
For non-adrenaline rhythms the outcome was com-
parable and was 0.8% vs. 0.9%, respectively (RR = 
= 0.94; 95% CI 0.16–5.50; p = 0.94) [21, 22, 28, 33].
Long-period outcome
Two studies reported 3-month survival rates 
[16, 20]. Higher survival rates were observed 
for adrenaline (3.7%), while for non-adrenaline 
treatment the survival rate was 2.8% (RR = 1.34; 
95% CI 1.06–1.68; p = 0.01). One study, Perkins 
et al. [16] reported good neurological outcome at 
3 months. Better results were obtained with adren-
aline compared to the non-adrenaline group (2.1% 
vs. 1.6%; RR = 1.30; 95% CI 0.94–1.80; p = 0.11).
 Quality of evidence
The risk of bias in the included RCTs as well 
as nonrandomized studies is summarized in Sup-
plementary Digital File 1. Only four studies 
were randomized controlled trials. The risk of 
bias was assessed as low or moderate in most of 
the studies.
Discussion
The main finding was as follows: (1) the use 
of adrenaline increased the chances of ROSC; 
(2) adrenaline was associated with increased sur-
vival to hospital discharge rate, however, survival 
to discharge with favorable neurological outcome 
was better in the non-adrenaline group.
 Studies published in recent years on the use 
of adrenaline in SCA are extremely important 
because of the large number of participants and 













































enough data for extraction
Full-text articles excluded,
with reasons:
no data availability (12),
duplicates (4), unrelated
topic (5), not comparative
studies (3), animal (2)
Figure 1. Flow diagram showing stages of database searching and study selection.
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a double-blinded placebo. The data obtained in this 
meta-analysis again indicates the need to consider 
the usefulness of routine adrenaline administration 
in SCA. While the use of adrenaline has been shown 
to increase the ROSC and survival to hospital dis-
charge, it does not affect the favorable neurological 
outcome. The results suggest considering routine 
adrenaline use in case of out-of-hospital SCA.
Return of spontaneous circulation is one of 
the basic outcomes of resuscitation, especially 
in the prehospital setting [34]. Pooled analysis 
showed that the use of adrenaline increases the 
chance of ROSC, which was evident in both RCTs 
and observational studies. It was apparent that 
administration of adrenaline for shockable rhythms 
was associated with a lower incidence of ROSC. 
It should be noted, however, that adrenaline is 
administered according to the guidelines only after 
ineffective defibrillation, not from the initiation 
of CPR procedures. In the case of non-shockable 
rhythms, the difference in ROSC was very signifi-
cant, ROSC was 19.4% for adrenaline and 4.3% for 
non-adrenaline treatment.
Another important element is survival to dis-
charge, where, as in the case of ROSC, it was ob-
served that for non-shockable rhythms, the use of 
adrenaline compared to non-adrenaline treatment 
was associated with higher survival to hospital 
discharge rate, however, these differences were 
not statistically significant. Again, as for ROSC for 
shockable rhythms, higher survival to discharge 
was observed in the non-adrenaline group.
Survival to discharge with the favorable neu-
rological outcome is essential for the functioning 
of the patient after the SCA incident with a sat-
isfactory quality of life. In the case of shockable 
rhythms, the use of adrenaline was associated with 
a statistically significantly worse prognosis. 
The administration of adrenaline in SCA is one 
of the key elements of resuscitation, especially in 
cases of non-shockable rhythms [5, 6]. However, 
it should be noted that there are many milestones 
in the history of the development of guidelines 
for resuscitation and many changes have been 
milestones, including the issue of ratio of chest 
compressions to the number of breaths, the use 
of defibrillation, including automated external de-
fibrillator, and improved quality of chest compres-
sions or airway management, where supraglottic 
airway devices were introduced and less emphasis 
on the need for endotracheal intubation.
There were also changes in pharmacotherapy 
in sudden cardiac arrest; over the years, the adrena-
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Figure 2. Forest plot of return of spontaneous circulation in adrenaline vs. non-adrenaline groups. The center of each 
square represents the relative risk for individual trials, and the corresponding horizontal line stands for a 95% confi-
dence interval (CI). The diamonds represent pooled results; RCT — randomized controlled trial.
Figure 3. Forest plot of return of spontaneous circulation by type of rhythm in adrenaline vs. non-adrenaline groups. 
The center of each square represents the relative risk for individual trials, and the corresponding horizontal line stands 
for a 95% confidence interval (CI). The diamonds represent pooled results.
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Figure 4. Forest plot of survival to hospital discharge in adrenaline vs. non-adrenaline groups. The center of each 
square represents the relative risk for individual trials, and the corresponding horizontal line stands for a 95% confi-
dence interval (CI). The diamonds represent pooled results; RCTs — randomized controlled trials.
Figure 5. Forest plot of survival to hospital discharge by type of rhythm in adrenaline vs. non-adrenaline groups. The 
center of each square represents the relative risk for individual trials, and the corresponding horizontal line stands for 
a 95% confidence interval (CI). The diamonds represent pooled results.
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that for non-shockable rhythms adrenaline is not 
administered immediately after SCA recognition. 
Perhaps the next stage will be the re-analysis of 
indications for adrenaline administration in SCA at 
the pre-hospital and hospital stages for shockable 
and non-shockable rhythms.
Changes in the guidelines and recommenda-
tions for resuscitation must be based on further 
scientific evidence based on high quality rand-
omized clinical trials conducted in both hospital and 
out-of-hospital settings [35]. Although achieving 
ROSC is a key task of the resuscitation team, the 
patient’s survival with a favorable neurological 
outcome is the most important goal and outcome. 
Both AHA and ERC guidelines are based on the 
analysis of scientific evidence and the most im-
portant are randomized double-blind clinical trials 
and meta-analyses including pooled data on large 
patient groups.
The advantage of the meta-analysis is the 
rigorous application of rules and criteria used in 
meta-analyses and a thorough search of available 
databases, as well as references in publications and 
manual searches in Google and Google Scholar, 
and the web pages of reliable organizations (gray 
literature) and analyses of the results obtained as 
well as following PRISMA statement for conducting 
and reporting results and The MOOSE guidelines 
for observational studies.
Limitations of the study
The results reported in the present systematic 
review and meta-analysis are subject to several 
limitations. First, only four studies included in the 
meta-analysis were randomized controlled trials. 
Some outcome measures were not uniformly re-
ported across studies and, therefore, were difficult 
to combine in a meta-analysis. The studies ana-
lyzed differed significantly in terms of the number 
of participants. Another limitation relates to the 
inclusion of research only in the context of out-of-
-hospital cardiac arrest. The results of adrenaline 
administration during CPR in hospital conditions 
may be different. Therefore, further analyses are 
planned for in-hospital cardiac arrest. When ana-
lyzing the results obtained in this article, all the 
limitations typical for meta-analyses, including the 
risk of bias and heterogeneous studies, should also 
be considered.
Return of spontaneous circulation and the 
neurological outcome are significantly influenced 
by the quality of resuscitation, especially the 
quality of chest compressions [1, 36–38]. Unfor-
tunately, the analyzed studies did not routinely 
use devices and methods to monitor the quality of 
chest compression, and chest compression depth 
and rate, as well as full chest recoil, which has 
a significant impact on the overall quality of CPR 
and the overall outcome of the rescue proce-
dure. High-quality chest compressions consist of 
achieving the correct recommended compression 
depth, compressions rate, correct chest recoil, 
minimizing interruptions in chest compressions, 
as well as the highest possible percentage of cor-
rect compressions concerning all compressions 
carried out with the correct compression site 
[39–41]. The lack of chest compression quality 
measurement may affect the results [1], but this 
effect is reduced by the randomized nature of the 
double-blinded studies.
The results obtained underline the need for 
further research on the use of vasopressors in the 
course of CPR. Another factor to be taken into 
account is the need to establish a vascular access 
(intravenous or intraosseous) for the administra-
tion of drugs, which may cause difficulties during 
resuscitation [42]. If the routine supply of adrena-
line during CPR is discontinued, this may result in 
a lack of immediate need for intravascular access 
and may further increase the focus on high-quality 
chest compression, electrotherapy and ventila-
tion and the elimination of potentially reversible 
causes [5].
Conclusions
The present meta-analysis demonstrates that 
resuscitation with adrenaline is associated with 
the ROSC and survival to hospital discharge, but 
no higher effectiveness was noted for discharge 
with favorable neurological outcome. The analy-
sis showed higher effectiveness of ROSC and 
survival to hospital discharge in non-shockable 
rhythms. But more multicenter RCTs are needed 
in the future.
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